CompaniesOrigin Biosciences

Origin Biosciences

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

117

By Phase

PHASE2/PHASE3: 1PHASE2: 1PHASE1: 1

By Status

COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
NCT01735188
NCT02047461
NCT02629393
Hover over trial bars to see details

Recent Trials

NCT02629393Lead Sponsor
Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A
PHASE2/PHASE3Completed
5 participants
Started: May 31, 2016 · Completed: Oct 31, 2022
NCT02047461Lead Sponsor
Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treated With rcPMP
PHASE2Completed
8 participants
Started: Apr 30, 2014 · Completed: Oct 31, 2022
NCT01735188Lead Sponsor
A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies
N/ACompleted
65 participants
Started: Aug 31, 2013 · Completed: Jun 30, 2016
NCT01894165Lead Sponsor
Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers
PHASE1Completed
24 participants
Started: Jun 30, 2013 · Completed: Sep 30, 2013
NCT01640717Lead Sponsor
A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)
N/ACompleted
15 participants
Started: Nov 30, 2012 · Completed: Oct 31, 2014